The biomarker of cancer

The biomarker of cancer

  • CN 101,675,341 B
  • Filed: 12/19/2007
  • Issued: 08/08/2017
  • Est. Priority Date: 12/19/2006
  • Status: Active Grant
First Claim
Patent Images

1. contain SEQ ID NO:

  • 4 EN-2 peptides are preparing the use in being used to diagnosing or monitoring the kit that prostate cancer is in progressOn the way, wherein the diagnosis or monitoring are tested with coming from normal, cancer-free including comparing the amount of EN-2 peptides described in urine test samplesMeasured present in the normal control urine sample of person.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×